Cliff Asness's NGNE Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 15,061 shares of Neurogene Inc. (NGNE) worth $473,668, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in NGNE, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 4,750 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Neurogene (NGNE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Neurogene (NGNE) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +4,750 | Add 46.07% | 15,061 | $31.45 |
| Q1 2026 | +10,311 | New Buy | 10,311 | $20.16 |
Cliff Asness's Neurogene Investment FAQs
Cliff Asness first purchased Neurogene Inc. (NGNE) in Q1 2026, acquiring 10,311 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Neurogene Inc. (NGNE) for 2 quarters since Q1 2026.
Cliff Asness's largest addition to Neurogene Inc. (NGNE) was in Q1 2026, adding 10,311 shares worth $207,870.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 15,061 shares of Neurogene Inc. (NGNE), valued at approximately $473,668.
As of the Q2 2026 filing, Neurogene Inc. (NGNE) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Neurogene Inc. (NGNE) was 15,061 shares, as reported at the end of Q2 2026.